Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 41,900 shares, a growth of 37.8% from the October 15th total of 30,400 shares. Currently, 1.7% of the company’s shares are sold […]
Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 29,200 shares, a drop of 22.8% from the August 31st total of 37,800 shares. Based on an average daily trading volume, of […]
Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) had its price target lifted by HC Wainwright from $12.00 to $23.00 in a research note published on Friday morning, Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other brokerages also recently commented on APTO. Cantor Fitzgerald increased their […]
Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s stock price hit a new 52-week low on Thursday . The company traded as low as C$5.88 and last traded at C$5.88, with a volume of 2123 shares traded. The stock had previously closed at C$6.02. Aptose Biosciences Price Performance The company has a quick ratio […]
Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) had its price target raised by Cantor Fitzgerald from $6.00 to $38.00 in a research report sent to investors on Monday morning, The Fly reports. A number of other research analysts have also recently issued reports on APTO. Piper Sandler decreased their price objective on shares of Aptose […]